— Know what they know.
Not Investment Advice

IGNE OTC

Igene Biotechnology, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -90.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Basic Materials · Agricultural Inputs · Tech Score Neutral · Power 48 · $15654 mcap · 1.29B float · 0.0051% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.00001
Volume50,560
Avg Volume65,323
Beta0.17
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoseph L. Downs
Employees18
SectorBasic Materials
IndustryAgricultural Inputs
IPO Date1995-02-02
Websiteigene.com
9110 Red Branch Road
Columbia, MD 21045
US
410-997-2599
About Igene Biotechnology, Inc.

Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
KIMELMAN MICHAEL S-Sale 8,000,000 $0.00 2010-10-20
KIMELMAN MICHAEL M-Exempt 9,986,904 $0.01 2009-07-16
KIMELMAN MICHAEL M-Exempt 10,100,066 $0.01 2009-07-16
KIMELMAN MICHAEL C-Conversion 14,000,000 $0.01 2009-07-16
KIMELMAN MICHAEL C-Conversion 11,000,000 $0.01 2009-07-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms